University of California, San Diego, School of Medicine, San Diego, California, USA.
Global Health Policy and Data Institute, San Diego, California, USA.
Psychooncology. 2023 Sep;32(9):1395-1400. doi: 10.1002/pon.6190. Epub 2023 Jul 6.
Cancer patients often face multiple comorbidities and are at risk for various mental health conditions and substance use disorders. Tobacco/nicotine dependence (TND) is a known risk factor for poor health outcomes and has been associated with psychiatric disorders including substance use disorder. However, the specific relationship between TND and the risk of substance use disorder and mental health conditions among cancer patients remains underexplored. This study aimed to assess the association between TND and the risk of comorbid conditions among cancer patients.
Data were obtained from a database of electronic health records for patients from the University of California health system. The odds for every condition among cancer patients with TND were calculated and compared with those for cancer patients without TND. ORs were adjusted for gender, ethnicity, and race.
Three thousand seven hundred and ninety-one cancer patients with TND had 252,619 total conditions, and 51,711 cancer patients without TND had 2,310,880 conditions. After adjusting for confounders, the condition for which TND most exacerbated risk was psychoactive substance-induced organic anxiety disorder (OR = 16.3, p < 0.001). This appeared consistent with the second, third, and fifth most-exacerbated conditions: stimulant use disorder (OR = 12.8, p < 0.001), cocaine induced mental disorder (OR = 11.0, p < 0.001), and cocaine use disorder (OR = 11.0, p < 0.001). Different conditions exacerbated by TND include acute alcoholic intoxication (OR = 11.4, p < 0.001), opioid use disorder (OR = 7.6, p < 0.001), schizoaffective disorder (OR = 7.4, p < 0.001), and cannabis use disorder (OR = 6.3, p < 0.001).
Our findings reveal a strong association between TND and an increased risk of substance use disorder and mental health conditions among cancer patients. Specifically, cancer patients with TND were at an elevated risk for psychoactive substance-induced organic anxiety disorder, stimulant use disorder, and cocaine-related disorders. Additionally, TND was associated with an increased risk of acute alcoholic intoxication, opioid use disorder, schizoaffective disorder, and cannabis use disorder. These findings underscore the need for comprehensive screening and interventions to address TND and comorbid conditions among cancer patients.
癌症患者常面临多种合并症,且易出现各种心理健康问题和物质使用障碍。烟草/尼古丁依赖(Tobacco/Nicotine Dependence,TND)是不良健康结局的已知风险因素,且与包括物质使用障碍在内的精神障碍相关。然而,TND 与癌症患者物质使用障碍和心理健康问题风险之间的具体关系仍未得到充分探索。本研究旨在评估 TND 与癌症患者合并症风险之间的关系。
数据来自加利福尼亚大学健康系统电子病历数据库。计算了 TND 癌症患者的每种疾病的发病几率,并与无 TND 的癌症患者进行了比较。比值比(OR)根据性别、族裔和种族进行了调整。
3791 名患有 TND 的癌症患者共有 252619 种疾病,51711 名无 TND 的癌症患者共有 2310880 种疾病。在调整混杂因素后,TND 最能加重风险的疾病是精神活性物质诱发的有机焦虑障碍(OR=16.3,p<0.001)。这与第二、第三和第五个最易加重的疾病一致:兴奋剂使用障碍(OR=12.8,p<0.001)、可卡因诱发的精神障碍(OR=11.0,p<0.001)和可卡因使用障碍(OR=11.0,p<0.001)。TND 加重的其他疾病包括急性酒精中毒(OR=11.4,p<0.001)、阿片类药物使用障碍(OR=7.6,p<0.001)、分裂情感障碍(OR=7.4,p<0.001)和大麻使用障碍(OR=6.3,p<0.001)。
我们的研究结果揭示了 TND 与癌症患者物质使用障碍和心理健康问题风险增加之间的强烈关联。具体来说,患有 TND 的癌症患者患精神活性物质诱发的有机焦虑障碍、兴奋剂使用障碍和可卡因相关障碍的风险升高。此外,TND 与急性酒精中毒、阿片类药物使用障碍、分裂情感障碍和大麻使用障碍的风险增加相关。这些发现强调了需要对癌症患者进行全面筛查和干预,以解决 TND 和合并症问题。